English

PROTEON THERAPEUTICS INC

EDGAR

TARA Quarterly report (10-Q) · filed 2026-08-11

65 filing records in this dataset, filed from 2014-09-16 to 2026-08-11. Reported financial figures are available; chart coverage varies by period.

Inspect reported changes Compare with another company Historical disclosures Search filings Segments

Watchlist

Cash and cash equivalents: 17.1 million USD 2026-06-30 Source
Exact value

17076000 USD
Long-term debt including current maturities: Not available
Shares outstanding: 59.1 million shares 2026-06-30 Source
Exact value

59083935 shares

Reported share-count change

53.14% · 20.5 million shares

Year-over-year change in reported shares. Splits, issuance and buybacks can affect this figure; it does not isolate employee compensation or economic dilution.

Exact inputs and evidence

38581863 shares · 2025-06-30· Source
59083935 shares · 2026-06-30· Source

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2026-08-11.

Financial data available through: 2025-12-31.

Coverage by financial measure

revenue: No compatible figures in this window
Operating income: 7 of 11 periods available· newest 2025-12-31
Net income: 7 of 11 periods available· newest 2025-12-31
Operating cash flow: 7 of 11 periods available· newest 2025-12-31
Capital expenditure: 7 of 11 periods available· newest 2025-12-31
Total assets: 7 of 11 periods available· newest 2025-12-31
Total liabilities: 7 of 11 periods available· newest 2025-12-31
Current assets: 7 of 11 periods available· newest 2025-12-31
Current liabilities: 7 of 11 periods available· newest 2025-12-31
Cash and cash equivalents: 7 of 11 periods available· newest 2025-12-31
long term debt: No compatible figures in this window
Shares outstanding: 7 of 11 periods available· newest 2025-12-31

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

Net income
−USD 12.84 million

Prior period

−USD 44.6 million

2024-01-01 – 2024-12-31
Current period

−USD 57.44 million

2025-01-01 – 2025-12-31

Exact inputs and evidence

-57439000 − -44596000 = -12843000 USD

-44596000 USD · 2024-01-01 – 2024-12-31
Inspect prior input Prior source
-57439000 USD · 2025-01-01 – 2025-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Net income · PROTEON THERAPEUTICS INC · 2025-12-31 PROTEON THERAPEUTICS INC (edgar:1359931) Year-over-year change in Net income: -12843000 USD Concept: fundies:NetIncome Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T18:39:58Z Snapshot: 6d1bbb98deab80b40a538703d34d9cc30456096df7432c0abbf374a043a17791 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1359931?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:NetIncome: -57439000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1359931/000121390026025433/ea0277639-10k_protara.htm#1344651 Filing: 000121390026025433 Input fundies:NetIncome: -44596000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1359931/000121390026025433/ea0277639-10k_protara.htm#1345115 Filing: 000121390026025433
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
−USD 20.56 million

Prior period

−USD 35.81 million

2024-01-01 – 2024-12-31
Current period

−USD 56.37 million

2025-01-01 – 2025-12-31

Exact inputs and evidence

-56365000 − -35808000 = -20557000 USD

-35808000 USD · 2024-01-01 – 2024-12-31
Inspect prior input Prior source
-56365000 USD · 2025-01-01 – 2025-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Operating cash flow · PROTEON THERAPEUTICS INC · 2025-12-31 PROTEON THERAPEUTICS INC (edgar:1359931) Year-over-year change in Operating cash flow: -20557000 USD Concept: fundies:OperatingCashFlow Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T18:39:58Z Snapshot: 6d1bbb98deab80b40a538703d34d9cc30456096df7432c0abbf374a043a17791 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1359931?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:OperatingCashFlow: -56365000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1359931/000121390026025433/ea0277639-10k_protara.htm#937335 Filing: 000121390026025433 Input fundies:OperatingCashFlow: -35808000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1359931/000121390026025433/ea0277639-10k_protara.htm#937791 Filing: 000121390026025433
The citation records this snapshot. The page link may show a newer release later.
Capital expenditure
+49.2%

Prior period

USD 63,000

2024-01-01 – 2024-12-31
Current period

USD 94,000

2025-01-01 – 2025-12-31

Exact inputs and evidence

94000 − 63000 = 31000 USD

63000 USD · 2024-01-01 – 2024-12-31
Inspect prior input Prior source
94000 USD · 2025-01-01 – 2025-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Capital expenditure · PROTEON THERAPEUTICS INC · 2025-12-31 PROTEON THERAPEUTICS INC (edgar:1359931) Year-over-year change in Capital expenditure: 31000 USD Concept: fundies:CapitalExpenditure Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T18:39:58Z Snapshot: 6d1bbb98deab80b40a538703d34d9cc30456096df7432c0abbf374a043a17791 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1359931?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:CapitalExpenditure: 94000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1359931/000121390026025433/ea0277639-10k_protara.htm#941071 Filing: 000121390026025433 Input fundies:CapitalExpenditure: 63000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1359931/000121390026025433/ea0277639-10k_protara.htm#941514 Filing: 000121390026025433
The citation records this snapshot. The page link may show a newer release later.

Comparable inputs unavailable for: Revenue.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

Revenue is not reported for this company, so its costs cannot be shown as a share of it.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

Not enough comparable data to show this history.

Values and sources

Revenue values and source evidence
Period	Series	Value	Source evidence

Revenue growth

Change in revenue from the same financial period one year earlier.

Not enough comparable data to show this history.

Values and sources

Revenue growth values and source evidence
Period	Series	Value	Source evidence

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Not enough comparable data to show this history.

Operating margin
Net margin
Free cash flow margin

Values and sources

Profit margins values and source evidence
Period	Series	Value	Source evidence

Operating cash flow

Cash generated by the company’s normal business operations.

Not enough comparable data to show this history.

Values and sources

Operating cash flow values and source evidence
Period	Series	Value	Source evidence

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

Not enough comparable data to show this history.

Values and sources

Free cash flow values and source evidence
Period	Series	Value(USD)	Source evidence

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

Not enough comparable data to show this history.

Values and sources

Liabilities to assets values and source evidence
Period	Series	Value	Source evidence

Current assets to current liabilities

Current assets divided by current liabilities.

Not enough comparable data to show this history.

Values and sources

Current assets to current liabilities values and source evidence
Period	Series	Value	Source evidence

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
Period	Net income	Operating cash flow	Capital expenditure	Free cash flow
2019 2019-01-01 – 2019-12-31	−USD 7.83 million Exact value Exact value: -7830000 USD 2019-01-01 – 2019-12-31: -7830000 USD Inspect Net Income Open source Share or cite Citation for Net Income · PROTEON THERAPEUTICS INC · 2019-12-31 PROTEON THERAPEUTICS INC (edgar:1359931) Net Income: -7830000 USD Concept: fundies:NetIncome Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T18:39:58Z Snapshot: 6d1bbb98deab80b40a538703d34d9cc30456096df7432c0abbf374a043a17791 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1359931/explain?concept=fundies%3ANetIncome&period=2019-12-31&surface=latest&period_type=duration&start=2019-01-01&unit=USD&dimensions= Input fundies:NetIncome: -7830000 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1359931/000121390021014709/tara-20201231.xml#470824 Filing: 000121390021014709 The citation records this snapshot. The page link may show a newer release later.	−USD 5.01 million Exact value Exact value: -5011000 USD 2019-01-01 – 2019-12-31: -5011000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · PROTEON THERAPEUTICS INC · 2019-12-31 PROTEON THERAPEUTICS INC (edgar:1359931) Operating Cash Flow: -5011000 USD Concept: fundies:OperatingCashFlow Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T18:39:58Z Snapshot: 6d1bbb98deab80b40a538703d34d9cc30456096df7432c0abbf374a043a17791 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1359931/explain?concept=fundies%3AOperatingCashFlow&period=2019-12-31&surface=latest&period_type=duration&start=2019-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -5011000 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1359931/000121390021014709/tara-20201231.xml#471252 Filing: 000121390021014709 The citation records this snapshot. The page link may show a newer release later.	USD 475,000 Exact value Exact value: 475000 USD 2019-01-01 – 2019-12-31: 475000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · PROTEON THERAPEUTICS INC · 2019-12-31 PROTEON THERAPEUTICS INC (edgar:1359931) Capital Expenditure: 475000 USD Concept: fundies:CapitalExpenditure Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T18:39:58Z Snapshot: 6d1bbb98deab80b40a538703d34d9cc30456096df7432c0abbf374a043a17791 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1359931/explain?concept=fundies%3ACapitalExpenditure&period=2019-12-31&surface=latest&period_type=duration&start=2019-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 475000 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1359931/000121390021014709/tara-20201231.xml#461586 Filing: 000121390021014709 The citation records this snapshot. The page link may show a newer release later.	−USD 5.49 million Calculation and evidence -5011000 − 475000 USD Exact free cash flow: -5486000 USD 2019-01-01 – 2019-12-31: -5011000 USD · Inspect Operating Cash Flow · Source 2019-01-01 – 2019-12-31: 475000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · PROTEON THERAPEUTICS INC · 2019-12-31 PROTEON THERAPEUTICS INC (edgar:1359931) Free cash flow: -5486000 USD Concept: free-cash-flow Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T18:39:58Z Snapshot: 6d1bbb98deab80b40a538703d34d9cc30456096df7432c0abbf374a043a17791 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1359931?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -5011000 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1359931/000121390021014709/tara-20201231.xml#471252 Filing: 000121390021014709 Input fundies:CapitalExpenditure: 475000 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1359931/000121390021014709/tara-20201231.xml#461586 Filing: 000121390021014709 The citation records this snapshot. The page link may show a newer release later.
2020 2020-01-01 – 2020-12-31	−USD 33.98 million Exact value Exact value: -33978000 USD 2020-01-01 – 2020-12-31: -33978000 USD Inspect Net Income Open source Share or cite Citation for Net Income · PROTEON THERAPEUTICS INC · 2020-12-31 PROTEON THERAPEUTICS INC (edgar:1359931) Net Income: -33978000 USD Concept: fundies:NetIncome Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T18:39:58Z Snapshot: 6d1bbb98deab80b40a538703d34d9cc30456096df7432c0abbf374a043a17791 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1359931/explain?concept=fundies%3ANetIncome&period=2020-12-31&surface=latest&period_type=duration&start=2020-01-01&unit=USD&dimensions= Input fundies:NetIncome: -33978000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1359931/000121390022011208/f10k2021_protarathera.htm#916512 Filing: 000121390022011208 The citation records this snapshot. The page link may show a newer release later.	−USD 23.41 million Exact value Exact value: -23407000 USD 2020-01-01 – 2020-12-31: -23407000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · PROTEON THERAPEUTICS INC · 2020-12-31 PROTEON THERAPEUTICS INC (edgar:1359931) Operating Cash Flow: -23407000 USD Concept: fundies:OperatingCashFlow Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T18:39:58Z Snapshot: 6d1bbb98deab80b40a538703d34d9cc30456096df7432c0abbf374a043a17791 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1359931/explain?concept=fundies%3AOperatingCashFlow&period=2020-12-31&surface=latest&period_type=duration&start=2020-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -23407000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1359931/000121390022011208/f10k2021_protarathera.htm#951884 Filing: 000121390022011208 The citation records this snapshot. The page link may show a newer release later.	USD 884,000 Exact value Exact value: 884000 USD 2020-01-01 – 2020-12-31: 884000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · PROTEON THERAPEUTICS INC · 2020-12-31 PROTEON THERAPEUTICS INC (edgar:1359931) Capital Expenditure: 884000 USD Concept: fundies:CapitalExpenditure Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T18:39:58Z Snapshot: 6d1bbb98deab80b40a538703d34d9cc30456096df7432c0abbf374a043a17791 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1359931/explain?concept=fundies%3ACapitalExpenditure&period=2020-12-31&surface=latest&period_type=duration&start=2020-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 884000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1359931/000121390022011208/f10k2021_protarathera.htm#956014 Filing: 000121390022011208 The citation records this snapshot. The page link may show a newer release later.	−USD 24.29 million Calculation and evidence -23407000 − 884000 USD Exact free cash flow: -24291000 USD 2020-01-01 – 2020-12-31: -23407000 USD · Inspect Operating Cash Flow · Source 2020-01-01 – 2020-12-31: 884000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · PROTEON THERAPEUTICS INC · 2020-12-31 PROTEON THERAPEUTICS INC (edgar:1359931) Free cash flow: -24291000 USD Concept: free-cash-flow Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T18:39:58Z Snapshot: 6d1bbb98deab80b40a538703d34d9cc30456096df7432c0abbf374a043a17791 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1359931?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -23407000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1359931/000121390022011208/f10k2021_protarathera.htm#951884 Filing: 000121390022011208 Input fundies:CapitalExpenditure: 884000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1359931/000121390022011208/f10k2021_protarathera.htm#956014 Filing: 000121390022011208 The citation records this snapshot. The page link may show a newer release later.
2021 2021-01-01 – 2021-12-31	−USD 47.25 million Exact value Exact value: -47252000 USD 2021-01-01 – 2021-12-31: -47252000 USD Inspect Net Income Open source Share or cite Citation for Net Income · PROTEON THERAPEUTICS INC · 2021-12-31 PROTEON THERAPEUTICS INC (edgar:1359931) Net Income: -47252000 USD Concept: fundies:NetIncome Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T18:39:58Z Snapshot: 6d1bbb98deab80b40a538703d34d9cc30456096df7432c0abbf374a043a17791 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1359931/explain?concept=fundies%3ANetIncome&period=2021-12-31&surface=latest&period_type=duration&start=2021-01-01&unit=USD&dimensions= Input fundies:NetIncome: -47252000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1359931/000121390023018373/f10k2022_protarathera.htm#809993 Filing: 000121390023018373 The citation records this snapshot. The page link may show a newer release later.	−USD 34.5 million Exact value Exact value: -34502000 USD 2021-01-01 – 2021-12-31: -34502000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · PROTEON THERAPEUTICS INC · 2021-12-31 PROTEON THERAPEUTICS INC (edgar:1359931) Operating Cash Flow: -34502000 USD Concept: fundies:OperatingCashFlow Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T18:39:58Z Snapshot: 6d1bbb98deab80b40a538703d34d9cc30456096df7432c0abbf374a043a17791 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1359931/explain?concept=fundies%3AOperatingCashFlow&period=2021-12-31&surface=latest&period_type=duration&start=2021-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -34502000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1359931/000121390023018373/f10k2022_protarathera.htm#819900 Filing: 000121390023018373 The citation records this snapshot. The page link may show a newer release later.	USD 596,000 Exact value Exact value: 596000 USD 2021-01-01 – 2021-12-31: 596000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · PROTEON THERAPEUTICS INC · 2021-12-31 PROTEON THERAPEUTICS INC (edgar:1359931) Capital Expenditure: 596000 USD Concept: fundies:CapitalExpenditure Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T18:39:58Z Snapshot: 6d1bbb98deab80b40a538703d34d9cc30456096df7432c0abbf374a043a17791 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1359931/explain?concept=fundies%3ACapitalExpenditure&period=2021-12-31&surface=latest&period_type=duration&start=2021-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 596000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1359931/000121390023018373/f10k2022_protarathera.htm#823529 Filing: 000121390023018373 The citation records this snapshot. The page link may show a newer release later.	−USD 35.1 million Calculation and evidence -34502000 − 596000 USD Exact free cash flow: -35098000 USD 2021-01-01 – 2021-12-31: -34502000 USD · Inspect Operating Cash Flow · Source 2021-01-01 – 2021-12-31: 596000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · PROTEON THERAPEUTICS INC · 2021-12-31 PROTEON THERAPEUTICS INC (edgar:1359931) Free cash flow: -35098000 USD Concept: free-cash-flow Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T18:39:58Z Snapshot: 6d1bbb98deab80b40a538703d34d9cc30456096df7432c0abbf374a043a17791 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1359931?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -34502000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1359931/000121390023018373/f10k2022_protarathera.htm#819900 Filing: 000121390023018373 Input fundies:CapitalExpenditure: 596000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1359931/000121390023018373/f10k2022_protarathera.htm#823529 Filing: 000121390023018373 The citation records this snapshot. The page link may show a newer release later.
2022 2022-01-01 – 2022-12-31	−USD 65.95 million Exact value Exact value: -65952000 USD 2022-01-01 – 2022-12-31: -65952000 USD Inspect Net Income Open source Share or cite Citation for Net Income · PROTEON THERAPEUTICS INC · 2022-12-31 PROTEON THERAPEUTICS INC (edgar:1359931) Net Income: -65952000 USD Concept: fundies:NetIncome Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T18:39:58Z Snapshot: 6d1bbb98deab80b40a538703d34d9cc30456096df7432c0abbf374a043a17791 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1359931/explain?concept=fundies%3ANetIncome&period=2022-12-31&surface=latest&period_type=duration&start=2022-01-01&unit=USD&dimensions= Input fundies:NetIncome: -65952000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1359931/000121390024021982/f10k2023_protarathera.htm#885674 Filing: 000121390024021982 The citation records this snapshot. The page link may show a newer release later.	−USD 26.46 million Exact value Exact value: -26457000 USD 2022-01-01 – 2022-12-31: -26457000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · PROTEON THERAPEUTICS INC · 2022-12-31 PROTEON THERAPEUTICS INC (edgar:1359931) Operating Cash Flow: -26457000 USD Concept: fundies:OperatingCashFlow Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T18:39:58Z Snapshot: 6d1bbb98deab80b40a538703d34d9cc30456096df7432c0abbf374a043a17791 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1359931/explain?concept=fundies%3AOperatingCashFlow&period=2022-12-31&surface=latest&period_type=duration&start=2022-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -26457000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1359931/000121390024021982/f10k2023_protarathera.htm#895664 Filing: 000121390024021982 The citation records this snapshot. The page link may show a newer release later.	USD 120,000 Exact value Exact value: 120000 USD 2022-01-01 – 2022-12-31: 120000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · PROTEON THERAPEUTICS INC · 2022-12-31 PROTEON THERAPEUTICS INC (edgar:1359931) Capital Expenditure: 120000 USD Concept: fundies:CapitalExpenditure Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T18:39:58Z Snapshot: 6d1bbb98deab80b40a538703d34d9cc30456096df7432c0abbf374a043a17791 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1359931/explain?concept=fundies%3ACapitalExpenditure&period=2022-12-31&surface=latest&period_type=duration&start=2022-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 120000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1359931/000121390024021982/f10k2023_protarathera.htm#899214 Filing: 000121390024021982 The citation records this snapshot. The page link may show a newer release later.	−USD 26.58 million Calculation and evidence -26457000 − 120000 USD Exact free cash flow: -26577000 USD 2022-01-01 – 2022-12-31: -26457000 USD · Inspect Operating Cash Flow · Source 2022-01-01 – 2022-12-31: 120000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · PROTEON THERAPEUTICS INC · 2022-12-31 PROTEON THERAPEUTICS INC (edgar:1359931) Free cash flow: -26577000 USD Concept: free-cash-flow Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T18:39:58Z Snapshot: 6d1bbb98deab80b40a538703d34d9cc30456096df7432c0abbf374a043a17791 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1359931?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -26457000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1359931/000121390024021982/f10k2023_protarathera.htm#895664 Filing: 000121390024021982 Input fundies:CapitalExpenditure: 120000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1359931/000121390024021982/f10k2023_protarathera.htm#899214 Filing: 000121390024021982 The citation records this snapshot. The page link may show a newer release later.
2023 2023-01-01 – 2023-12-31	−USD 40.42 million Exact value Exact value: -40420000 USD 2023-01-01 – 2023-12-31: -40420000 USD Inspect Net Income Open source Share or cite Citation for Net Income · PROTEON THERAPEUTICS INC · 2023-12-31 PROTEON THERAPEUTICS INC (edgar:1359931) Net Income: -40420000 USD Concept: fundies:NetIncome Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-02T18:39:58Z Snapshot: 6d1bbb98deab80b40a538703d34d9cc30456096df7432c0abbf374a043a17791 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1359931/explain?concept=fundies%3ANetIncome&period=2023-12-31&surface=latest&period_type=duration&start=2023-01-01&unit=USD&dimensions= Input fundies:NetIncome: -40420000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1359931/000121390025020368/ea0231646-10k_protara.htm#1267683 Filing: 000121390025020368 The citation records this snapshot. The page link may show a newer release later.	−USD 37.56 million Exact value Exact value: -37557000 USD 2023-01-01 – 2023-12-31: -37557000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · PROTEON THERAPEUTICS INC · 2023-12-31 PROTEON THERAPEUTICS INC (edgar:1359931) Operating Cash Flow: -37557000 USD Concept: fundies:OperatingCashFlow Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-02T18:39:58Z Snapshot: 6d1bbb98deab80b40a538703d34d9cc30456096df7432c0abbf374a043a17791 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1359931/explain?concept=fundies%3AOperatingCashFlow&period=2023-12-31&surface=latest&period_type=duration&start=2023-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -37557000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1359931/000121390025020368/ea0231646-10k_protara.htm#864166 Filing: 000121390025020368 The citation records this snapshot. The page link may show a newer release later.	USD 45,000 Exact value Exact value: 45000 USD 2023-01-01 – 2023-12-31: 45000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · PROTEON THERAPEUTICS INC · 2023-12-31 PROTEON THERAPEUTICS INC (edgar:1359931) Capital Expenditure: 45000 USD Concept: fundies:CapitalExpenditure Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-02T18:39:58Z Snapshot: 6d1bbb98deab80b40a538703d34d9cc30456096df7432c0abbf374a043a17791 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1359931/explain?concept=fundies%3ACapitalExpenditure&period=2023-12-31&surface=latest&period_type=duration&start=2023-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 45000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1359931/000121390025020368/ea0231646-10k_protara.htm#867670 Filing: 000121390025020368 The citation records this snapshot. The page link may show a newer release later.	−USD 37.6 million Calculation and evidence -37557000 − 45000 USD Exact free cash flow: -37602000 USD 2023-01-01 – 2023-12-31: -37557000 USD · Inspect Operating Cash Flow · Source 2023-01-01 – 2023-12-31: 45000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · PROTEON THERAPEUTICS INC · 2023-12-31 PROTEON THERAPEUTICS INC (edgar:1359931) Free cash flow: -37602000 USD Concept: free-cash-flow Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-02T18:39:58Z Snapshot: 6d1bbb98deab80b40a538703d34d9cc30456096df7432c0abbf374a043a17791 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1359931?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -37557000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1359931/000121390025020368/ea0231646-10k_protara.htm#864166 Filing: 000121390025020368 Input fundies:CapitalExpenditure: 45000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1359931/000121390025020368/ea0231646-10k_protara.htm#867670 Filing: 000121390025020368 The citation records this snapshot. The page link may show a newer release later.
2024 2024-01-01 – 2024-12-31	−USD 44.6 million Exact value Exact value: -44596000 USD 2024-01-01 – 2024-12-31: -44596000 USD Inspect Net Income Open source Share or cite Citation for Net Income · PROTEON THERAPEUTICS INC · 2024-12-31 PROTEON THERAPEUTICS INC (edgar:1359931) Net Income: -44596000 USD Concept: fundies:NetIncome Period: 2024-01-01 to 2024-12-31 Values: Latest reported Published: 2026-11-02T18:39:58Z Snapshot: 6d1bbb98deab80b40a538703d34d9cc30456096df7432c0abbf374a043a17791 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1359931/explain?concept=fundies%3ANetIncome&period=2024-12-31&surface=latest&period_type=duration&start=2024-01-01&unit=USD&dimensions= Input fundies:NetIncome: -44596000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1359931/000121390026025433/ea0277639-10k_protara.htm#1345115 Filing: 000121390026025433 The citation records this snapshot. The page link may show a newer release later.	−USD 35.81 million Exact value Exact value: -35808000 USD 2024-01-01 – 2024-12-31: -35808000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · PROTEON THERAPEUTICS INC · 2024-12-31 PROTEON THERAPEUTICS INC (edgar:1359931) Operating Cash Flow: -35808000 USD Concept: fundies:OperatingCashFlow Period: 2024-01-01 to 2024-12-31 Values: Latest reported Published: 2026-11-02T18:39:58Z Snapshot: 6d1bbb98deab80b40a538703d34d9cc30456096df7432c0abbf374a043a17791 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1359931/explain?concept=fundies%3AOperatingCashFlow&period=2024-12-31&surface=latest&period_type=duration&start=2024-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -35808000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1359931/000121390026025433/ea0277639-10k_protara.htm#937791 Filing: 000121390026025433 The citation records this snapshot. The page link may show a newer release later.	USD 63,000 Exact value Exact value: 63000 USD 2024-01-01 – 2024-12-31: 63000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · PROTEON THERAPEUTICS INC · 2024-12-31 PROTEON THERAPEUTICS INC (edgar:1359931) Capital Expenditure: 63000 USD Concept: fundies:CapitalExpenditure Period: 2024-01-01 to 2024-12-31 Values: Latest reported Published: 2026-11-02T18:39:58Z Snapshot: 6d1bbb98deab80b40a538703d34d9cc30456096df7432c0abbf374a043a17791 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1359931/explain?concept=fundies%3ACapitalExpenditure&period=2024-12-31&surface=latest&period_type=duration&start=2024-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 63000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1359931/000121390026025433/ea0277639-10k_protara.htm#941514 Filing: 000121390026025433 The citation records this snapshot. The page link may show a newer release later.	−USD 35.87 million Calculation and evidence -35808000 − 63000 USD Exact free cash flow: -35871000 USD 2024-01-01 – 2024-12-31: -35808000 USD · Inspect Operating Cash Flow · Source 2024-01-01 – 2024-12-31: 63000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · PROTEON THERAPEUTICS INC · 2024-12-31 PROTEON THERAPEUTICS INC (edgar:1359931) Free cash flow: -35871000 USD Concept: free-cash-flow Period: 2024-01-01 to 2024-12-31 Values: Latest reported Published: 2026-11-02T18:39:58Z Snapshot: 6d1bbb98deab80b40a538703d34d9cc30456096df7432c0abbf374a043a17791 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1359931?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -35808000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1359931/000121390026025433/ea0277639-10k_protara.htm#937791 Filing: 000121390026025433 Input fundies:CapitalExpenditure: 63000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1359931/000121390026025433/ea0277639-10k_protara.htm#941514 Filing: 000121390026025433 The citation records this snapshot. The page link may show a newer release later.
2025 2025-01-01 – 2025-12-31	−USD 57.44 million Exact value Exact value: -57439000 USD 2025-01-01 – 2025-12-31: -57439000 USD Inspect Net Income Open source Share or cite Citation for Net Income · PROTEON THERAPEUTICS INC · 2025-12-31 PROTEON THERAPEUTICS INC (edgar:1359931) Net Income: -57439000 USD Concept: fundies:NetIncome Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T18:39:58Z Snapshot: 6d1bbb98deab80b40a538703d34d9cc30456096df7432c0abbf374a043a17791 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1359931/explain?concept=fundies%3ANetIncome&period=2025-12-31&surface=latest&period_type=duration&start=2025-01-01&unit=USD&dimensions= Input fundies:NetIncome: -57439000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1359931/000121390026025433/ea0277639-10k_protara.htm#1344651 Filing: 000121390026025433 The citation records this snapshot. The page link may show a newer release later.	−USD 56.37 million Exact value Exact value: -56365000 USD 2025-01-01 – 2025-12-31: -56365000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · PROTEON THERAPEUTICS INC · 2025-12-31 PROTEON THERAPEUTICS INC (edgar:1359931) Operating Cash Flow: -56365000 USD Concept: fundies:OperatingCashFlow Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T18:39:58Z Snapshot: 6d1bbb98deab80b40a538703d34d9cc30456096df7432c0abbf374a043a17791 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1359931/explain?concept=fundies%3AOperatingCashFlow&period=2025-12-31&surface=latest&period_type=duration&start=2025-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -56365000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1359931/000121390026025433/ea0277639-10k_protara.htm#937335 Filing: 000121390026025433 The citation records this snapshot. The page link may show a newer release later.	USD 94,000 Exact value Exact value: 94000 USD 2025-01-01 – 2025-12-31: 94000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · PROTEON THERAPEUTICS INC · 2025-12-31 PROTEON THERAPEUTICS INC (edgar:1359931) Capital Expenditure: 94000 USD Concept: fundies:CapitalExpenditure Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T18:39:58Z Snapshot: 6d1bbb98deab80b40a538703d34d9cc30456096df7432c0abbf374a043a17791 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1359931/explain?concept=fundies%3ACapitalExpenditure&period=2025-12-31&surface=latest&period_type=duration&start=2025-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 94000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1359931/000121390026025433/ea0277639-10k_protara.htm#941071 Filing: 000121390026025433 The citation records this snapshot. The page link may show a newer release later.	−USD 56.46 million Calculation and evidence -56365000 − 94000 USD Exact free cash flow: -56459000 USD 2025-01-01 – 2025-12-31: -56365000 USD · Inspect Operating Cash Flow · Source 2025-01-01 – 2025-12-31: 94000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · PROTEON THERAPEUTICS INC · 2025-12-31 PROTEON THERAPEUTICS INC (edgar:1359931) Free cash flow: -56459000 USD Concept: free-cash-flow Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T18:39:58Z Snapshot: 6d1bbb98deab80b40a538703d34d9cc30456096df7432c0abbf374a043a17791 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1359931?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -56365000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1359931/000121390026025433/ea0277639-10k_protara.htm#937335 Filing: 000121390026025433 Input fundies:CapitalExpenditure: 94000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1359931/000121390026025433/ea0277639-10k_protara.htm#941071 Filing: 000121390026025433 The citation records this snapshot. The page link may show a newer release later.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

65 filings · 3,213 latest values · 3,213 originally reported values

Dataset published 2026-11-02. Source filing dates and reporting periods are shown separately.

Identifiers: 0001359931, 1359931, TARA, edgar:1359931, prto, tara

Also known as ArTara Therapeutics, Inc., PROTEON THERAPEUTICS INC, Protara Therapeutics, Inc.

PROTEON THERAPEUTICS INC

Reported share-count change

Company performance

What changed year over year

Net income

Operating cash flow

Capital expenditure

Where revenue goes

Growth

Profit and cash

Balance sheet

Cash generation